CAPTRUST Financial Advisors
RCEL icon

CAPTRUST Financial Advisors’s Avita Medical RCEL Stock Holding History

CAPTRUST Financial Advisors’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-389
Closed -$3K – 5096
2022
Q1 		$3K Buy
+389
New +$3.58K ﹤0.01% 4380

Other funds holding RCEL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

CAPTRUST Financial Advisors's RCEL Position: Q2 2022 in Review

CAPTRUST Financial Advisors sold out of Avita Medical (RCEL) in Q2 2022, closing a stake of 389 shares — an estimated $3K sold.

CAPTRUST Financial Advisors first reported a position in RCEL in Q1 2022 and held it in 1 quarter. The position peaked at $3K in Q1 2022. 56 funds tracked by Wall St. Rank hold RCEL as of Q2 2022.

  • CAPTRUST Financial Advisors reported no remaining Avita Medical position as of Q2 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 389 Avita Medical shares in Q2 2022, an estimated $3K.
  • CAPTRUST Financial Advisors first reported a position in Avita Medical in Q1 2022 and held it in 1 quarter.
  • CAPTRUST Financial Advisors's Avita Medical position peaked at $3K in Q1 2022.
  • 56 funds tracked by Wall St. Rank held Avita Medical as of Q2 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2022, filed 16 Aug 2022.